NYSE:GSK | Market Exclusive

Home Tags NYSE:GSK

GlaxoSmithKline plc (NYSE:GSK) To Invest $360 Million In Britain Amid Brexit...

Andy Parker - July 28, 2016 0

Merck & Co., Inc. (NYSE:MRK) Ebola Vaccine Attains FDA And EMA...

- July 26, 2016 0

GlaxoSmithKline plc (NYSE:GSK) Receives Approval For HPV Vaccine In China

- July 19, 2016 0

Biogen Inc (NASDAQ:BIIB) Brings Lupus Candidate Back Into The Clinic

Andy Parker - July 14, 2016 0

GlaxoSmithKline plc (NYSE:GSK) Throws Hat In Zika Ring

Andy Parker - July 11, 2016 0

GlaxoSmithKline plc (NYSE:GSK), Pfizer Inc. (PFE) Lead $52M Fundraiser For Morphic

Andy Parker - July 1, 2016 0

Can Merck & Co., Inc. (NYSE:MRK)’s Gardasil Trigger More HPV Vaccine...

Andy Parker - June 22, 2016 0

Inovio Pharmaceuticals Inc (NASDAQ:INO) Jumps Ahead Of Sanofi (SNY) In Zika...

Andy Parker - June 22, 2016 0

GlaxoSmithKline PLC (NYSE:GSK) To Accelerate Filing For COPD Combo Treatment

Andy Parker - June 9, 2016 0

GlaxoSmithKline PLC (NYSE:GSK) Poised To Overtake Sanofi SA (NYSE:SNY) In This...

- June 8, 2016 0

1...678 9 Page 7 of 9

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NYSE:GSK